Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Study duration per participant is approximately 403 to 436 days
Epistemonikos ID: 13866a9ac5a7406c423f149332b2dd231a4f72e5
First added on: May 21, 2024